Pharvaris NV (PHVS)
21.46
+0.89
(+4.33%)
USD |
NASDAQ |
May 10, 16:00
20.99
-0.47
(-2.19%)
After-Hours: 20:00
Pharvaris EPS Diluted (Quarterly): -0.8185 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.8185 |
| September 30, 2023 | -0.6315 |
| June 30, 2023 | 0.0196 |
| March 31, 2023 | -0.7196 |
| December 31, 2022 | -1.186 |
| September 30, 2022 | -0.2518 |
| June 30, 2022 | -0.4048 |
| March 31, 2022 | -0.5386 |
| December 31, 2021 | -0.4232 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.3301 |
| June 30, 2021 | -0.5544 |
| March 31, 2021 | -0.7953 |
| December 31, 2020 | -0.4127 |
| September 30, 2020 | -0.2351 |
| June 30, 2020 | -0.1987 |
| March 31, 2020 | -0.1136 |
| December 31, 2019 | -0.1203 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.186
Minimum
Dec 2022
0.0196
Maximum
Jun 2023
-0.4538
Average
-0.4127
Median
Dec 2020
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.36 |
| ProQR Therapeutics NV | -0.0754 |
| Merus NV | -1.09 |
| argenx SE | -1.69 |
| Pharming Group | -0.05 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.27M |
| Total Expenses (Quarterly) | 29.27M |
| Enterprise Value | 722.44M |
| Earnings Yield | -10.02% |